Patent ID: 11951097
Assignee: VANDA PHARMACEUTICALS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 23:
24. A method of reinitiating treatment with ponesimod following a missed dose for a patient in need thereof, wherein the patient is being treated with titration doses comprising administering orally once daily 2 mg of ponesimod on days 1 and 2; 3 mg of ponesimod on days 3 and 4; 4 mg of ponesimod on days 5 and 6; 5 mg of ponesimod on day 7; 6 mg of ponesimod on day 8; 7 mg of ponesimod on day 9; 8 mg of ponesimod on day 10; 9 mg of ponesimod on day 11; and 10 mg of ponesimod on days 12, 13, and 14, followed by administering 20 mg of ponesimod once daily, and fewer than four consecutive titration doses have been missed, comprising resuming treatment with the first missed titration dose and resuming the titration at that dose and titration day.